Research location
Fair Oaks
California, United States
Advertisement
Research activity in Fair Oaks
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 32 trials and 32 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Fair Oaks
32 linked trials · page 1 of 1A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung CancerNCT07217301 · 2025-11-26 · 1 site observation
RECRUITING
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainNCT06848348 · 2025-02-21 · 1 site observation
ACTIVE_NOT_RECRUITING
An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential HypertensionNCT03514641 · 2017-10-18 · 1 site observation
COMPLETED
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid ArthritisNCT02831855 · 2016-09-01 · 1 site observation
COMPLETED
Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1KNCT02707406 · 2016-02-01 · 1 site observation
COMPLETED
Santyl Applications to Diabetic Foot UlcersNCT02111291 · 2014-04-01 · 1 site observation
COMPLETED
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid ArthritisNCT02092467 · 2014-03-14 · 1 site observation
COMPLETED
Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to OlmesartanNCT01876368 · 2013-09-01 · 1 site observation
COMPLETED
Study of Oasis Ultra in Diabetic Foot UlcersNCT01835379 · 2013-05-01 · 1 site observation
COMPLETED
Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot UlcersNCT01830348 · 2013-02-01 · 1 site observation
TERMINATED
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot UlcersNCT01070433 · 2012-09-01 · 1 site observation
COMPLETED
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyNCT01676116 · 2012-08-29 · 1 site observation
COMPLETED
A Prospective, Randomized, Double-Blind Multicenter Study Comparing CDO Therapy to Standard MWT in the Treatment of DFUsNCT01645891 · 2012-04-01 · 1 site observation
COMPLETED
A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or PlaceboNCT01359150 · 2011-09-01 · 1 site observation
COMPLETED
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 DiabetesNCT01336023 · 2011-05-23 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and DiabetesNCT01368536 · 2011-05-01 · 1 site observation
TERMINATED
A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes MellitusNCT01106651 · 2010-06-01 · 1 site observation
COMPLETED
The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)NCT01106625 · 2010-05-01 · 1 site observation
COMPLETED
A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid ArthritisNCT00853385 · 2009-05-01 · 1 site observation
COMPLETED
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential HypertensionNCT00662896 · 2008-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of LCZ696A in Patients With Essential HypertensionNCT00549770 · 2007-09-01 · 1 site observation
COMPLETED
12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With MetforminNCT00473525 · 2007-07-01 · 1 site observation
COMPLETED
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid ArthritisNCT00413699 · 2007-02-05 · 1 site observation
COMPLETED
Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyNCT00425321 · 2006-12-01 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation
COMPLETED
A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate TherapyNCT00316771 · 2005-11-01 · 1 site observation
COMPLETED
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionNCT00095550 · 2004-10-01 · 1 site observation
COMPLETED
Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With AsthmaNCT00064389 · 2003-01-01 · 1 site observation
COMPLETED
To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDNCT00064415 · 2002-06-01 · 1 site observation
COMPLETED
Dose Ranging Study With LT, Monotherapy, PPARNCT00240383 · 2002-05-01 · 1 site observation
COMPLETED
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDNCT00064402 · 2002-04-01 · 1 site observation
COMPLETED
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideNCT00279045 · 2000-01-03 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.